Retatrutide Vial 20mg / 40mg
Retatrutide is a triple receptor agonist studied for its simultaneous activity at GLP-1, GIP, and glucagon receptors. It represents one of the most advanced areas of current metabolic research, with studies examining its effects on body composition, insulin sensitivity, and metabolic function. The triple agonist mechanism differentiates it from dual agonist compounds and has been the subject of significant published clinical research.
Available in 20mg and 40mg vials. Each vial contains lyophilised powder at ≥99% purity, third-party verified. Supplied with bacteriostatic water for reconstitution.
Research Areas
- Triple GLP-1/GIP/glucagon receptor agonism
- Metabolic function
- Body composition studies
- Insulin sensitivity research
Specifications
- Available in 20mg or 40mg
- ≥99% purity, third-party verified
- Includes bacteriostatic water
- Store refrigerated, away from light
For laboratory and research purposes only. Not intended for human consumption or medical use.